| PRLog Free Press Release | + Bookmark This Page |
Filter News Category Accounting Advertising Aerospace Affiliate Program Agriculture Apparel Architecture Arts Automotive Banking Beauty Biotech Books Business Computers Construction Consumer Defense Education Electronics Energy Engineering Entertainment Environment Event Family Fashion Finance Fitness Food Free Games Government Health Home Home Business Human Resources Industrial Insurance Internet Legal Lifestyle Literature Loans Manufacturing Marketing Media Medical Mobile Mortgage Movies Multimedia Music Non Profit Open Source Pets Photography Property Publishing Real Estate Religion Reports Research Restaurants Retail Science Security Semiconductors Services Shipping Shopping Society Software Sports Technology Telecom Textile Tourism Transportation Travel Wireless Country Afghanistan American Samoa Argentina Armenia Australia Austria Bahamas Bahrain Bangladesh Belarus Belgium Belize Benin Botswana Brazil Bulgaria Cambodia Canada China Colombia Costa Rica Croatia Cyprus Czech Republic Denmark Egypt Finland France Germany Gibraltar Greece Hong Kong Hungary Iceland India Indonesia Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Korea, Republic of Lao PDR Lebanon Liechtenstein Lithuania Malaysia Malta Mauritius Mexico Morocco Netherlands Netherlands Antilles New Zealand Nigeria Norway Pakistan Panama Philippines Poland Portugal Puerto Rico Romania Russian Federation Saudi Arabia Scotland Serbia & Montenegro Singapore Slovakia Slovenia South Africa Spain Sri Lanka Sweden Switzerland Taiwan Thailand Timor-Leste Trinidad & Tobago Turkey Ukraine United Arab Emirates United Kingdom United States United States MO Islands Vanuatu Viet Nam Zimbabwe State / Province Select Country FirstCity / Town Select State First | AEGIS Microbe Shield™ Technology effective againsts the deadly SARS and H5N1 virus.
FOR IMMEDIATE RELEASE
PRLog (Press Release) –
Feb 13, 2008 – Antiviral agents for use on inanimate surfaces have been the subject of research and commercial activities since the 1950s. Within this body of work the targets for inactivation have been hypothesized. Viruses are made up of a lipoprotein envelope with characteristics of a typical unit membrane, a proteinatious capsid, and the RNA or DNA genetic material.
These structures and their chemical make up offer targets for antiviral agents. The generally accepted hypothesis on mechanisms of inactivation is based on whether viruses are lipophilic (enveloped viruses such as herpes simplex) or hydrophilic (naked or non-enveloped viruses such as poliovirus). The active ingredient of the AEM 5700/5772 Antimicrobial has been tested in solution and on treated surfaces against a small range of viruses. Following are summaries of this work: Herpes Simplex A series of tests were run at Hill Top Research, Cincinnati, Ohio using a 1% solution of AEM 5700. The test method used was designed for disinfectant products used on an inanimate environmental surface for compliance with US EPA Pesticide Assessment Guidelines, Subdivision G: Product Performance, November, 1982. Viricidal activity was shown against Herpes simplex type 1, an enveloped virus). Poliovirus Type 2 In a static test run by Southern Research Institute, Birmingham, Alabama surfaces treated with the active ingredient of AEM 5700 showed viricidal activity against Poliovirus type 1 (Strain MEF- 1) (a non-enveloped RNA enterovirus. Bacteriophage T2 and Herpes Simplex Type 1 In a series of experiments and papers I-Fu (Eric) Tsao and Henry Y. Wang of the University of Michigan, Ann Arbor, Michigan tested the antiviral activity of AEM 5700 treated alginate beads in a flow through filtration system. Antiviral activity against bacteriophage T2 and herpes simplex virus type 1 (HSV-1) (an enveloped animal virus) was shown both in the presence and absence of proteins in the test solutions. Standard Quats Numerous papers have been written on the antiviral activity of standard quaternary ammonium compounds both in solution and when immobilized on inert supports. These papers show inactivation of lipid-containing viruses, some non-lipid viruses, and bacteriophages. No antiviral activity was shown for smaller non-lipid viruses such as piconaviruses Conclusions Test conducted in Malaysia confirm AEGIS MIcrobe Shield is effective againsts the deadly virus H5N1. Test paper is available upon your request. Please email to info@aegisasia.com AEM 5700 solutions and AEM 5700 treated surfaces show positive antiviral activity against a range of viral types. These results are encouraging regarding the utility of this treatment at reducing doses of viruses in a variety of applications. Interest in the potential activity of the AEM 5700 solution on treated surfaces against specific viruses must be pursued with specific tests. for more information on aegis microbe shield , please visit our website : http://www.aegisasia.com
Email to a Friend Email to Author Visit Press Room Previous News Next News
Disclaimer: Issuers of the press releases are solely responsible for the content of their press releases. PRLog.Org can't be held liable for the contents of the press releases. Report Abuse |
Previous News Next News For Businesses ... | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||